Heparin Prices are Soaring

Rick Patterson

Attorney

0 CommentsPrint ArticleSubscribe

It is a case of supply and demand with regard to the blood-thinning drug heparin. Since the recall of heparin earlier this year, supplies have become very limited, so an increase was to be expected.

For example, "At Renal Advantage's 90 dialysis centers, prices have gone up twice since mid-April, says Angela Newman, vice president. DaVita, which has 1,300 dialysis centers, has seen a similar jump, says spokeswoman Stephanie Horn." The increase shows no immediate signs of leveling off. The costs of crude heparin alone, which is imported from China, have risen 500% since the beginning of this year.

Additional Information Pertaining to the FDA and Perscription Drugs